Evidence map›Paper›PMID 29865227›Full record

Trial reportNutrients2018

Ferulic Acid Supplementation Improves Lipid Profiles, Oxidative Stress, and Inflammatory Status in Hyperlipidemic Subjects: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.

Akkarach Bumrungpert, Supathra Lilitchan, Siriporn Tuntipopipat, Nednapis Tirawanchai, Surat Komindr

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 99 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
99citing papers in PubMed, 2 pooled it
19.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

99 citing papers in PubMed, 2 syntheses or guidelines pooled it, 233 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Nutraceutical Profile Characterization in Apricot (Plants (Basel, Switzerland) · 2025
    Article
  17. Article
  18. Review
  19. Article
  20. Article

39 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Akkarach BumrungpertDepartment of Nutrition, Faculty of Public Health, Mahidol University, Bangkok 10400, Thailand. abnutrition@yahoo.com.
Supathra LilitchanDepartment of Nutrition, Faculty of Public Health, Mahidol University, Bangkok 10400, Thailand. supathra.lil@mahidol.ac.th.
Siriporn TuntipopipatInstitute of Nutrition, Mahidol University, Nakhonpathom 73170, Thailand. siriporn.tun@mahidol.ac.th.
Nednapis TirawanchaiDepartment of Biochemistry, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand. nednapis.tir@mahidol.ac.th.
Surat KomindrDepartment of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok 10400, Thailand. surat_komindr@yahoo.com.
Mahidol University · THRamathibodi Hospital · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ferulic acid is the most abundant phenolic compound found in vegetables and cereal grains. In vitro and animal studies have shown ferulic acid has anti-hyperlipidemic, anti-oxidative, and anti-inflammatory effects. The objective of this study is to investigate the effects of ferulic acid supplementation on lipid profiles, oxidative stress, and inflammatory status in hyperlipidemia. The study design is a randomized, double-blind, placebo-controlled trial. Subjects with hyperlipidemia were randomly divided into two groups. The treatment group (

Indexed as

Dietary SupplementsAdultAnti-Inflammatory AgentsAntioxidantsBiomarkersCoumaric AcidsDouble-Blind MethodFemaleHumansHyperlipidemiasHypolipidemic AgentsInflammation MediatorsLipidsMaleMiddle AgedOxidative StressAnti-Inflammatory AgentsAntioxidantsBiomarkersCoumaric Acidsferulic acidHypolipidemic AgentsInflammation MediatorsLipidsanti-inflammationanti-oxidantferulic acidlipid profilesphenolic compound

Identifiers

PMID29865227
PMCPMC6024557
OpenAlexW2805906447

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.